BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 28346452)

  • 1. Purine synthesis promotes maintenance of brain tumor initiating cells in glioma.
    Wang X; Yang K; Xie Q; Wu Q; Mack SC; Shi Y; Kim LJY; Prager BC; Flavahan WA; Liu X; Singer M; Hubert CG; Miller TE; Zhou W; Huang Z; Fang X; Regev A; Suvà ML; Hwang TH; Locasale JW; Bao S; Rich JN
    Nat Neurosci; 2017 May; 20(5):661-673. PubMed ID: 28346452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells.
    Wang X; Huang Z; Wu Q; Prager BC; Mack SC; Yang K; Kim LJY; Gimple RC; Shi Y; Lai S; Xie Q; Miller TE; Hubert CG; Song A; Dong Z; Zhou W; Fang X; Zhu Z; Mahadev V; Bao S; Rich JN
    Cancer Res; 2017 Sep; 77(18):4947-4960. PubMed ID: 28729418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rewiring of purine metabolism in response to acidosis stress in glioma stem cells.
    Xu X; Wang L; Zang Q; Li S; Li L; Wang Z; He J; Qiang B; Han W; Zhang R; Peng X; Abliz Z
    Cell Death Dis; 2021 Mar; 12(3):277. PubMed ID: 33723244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway.
    Lv Y; Wang X; Li X; Xu G; Bai Y; Wu J; Piao Y; Shi Y; Xiang R; Wang L
    PLoS Biol; 2020 Nov; 18(11):e3000872. PubMed ID: 33186350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DHFR targets the self-renewing potential of brain tumor initiating cells.
    Fawal MA; Jungas T; Davy A
    Cancer Lett; 2021 Apr; 503():129-137. PubMed ID: 33545223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
    Kim EJ; Kim SH; Jin X; Jin X; Kim H
    Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.
    Barfeld SJ; Fazli L; Persson M; Marjavaara L; Urbanucci A; Kaukoniemi KM; Rennie PS; Ceder Y; Chabes A; Visakorpi T; Mills IG
    Oncotarget; 2015 May; 6(14):12587-602. PubMed ID: 25869206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation.
    Xie Q; Wu Q; Kim L; Miller TE; Liau BB; Mack SC; Yang K; Factor DC; Fang X; Huang Z; Zhou W; Alazem K; Wang X; Bernstein BE; Bao S; Rich JN
    J Clin Invest; 2016 Jul; 126(7):2757-72. PubMed ID: 27322055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
    Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells.
    Kathagen A; Schulte A; Balcke G; Phillips HS; Martens T; Matschke J; Günther HS; Soriano R; Modrusan Z; Sandmann T; Kuhl C; Tissier A; Holz M; Krawinkel LA; Glatzel M; Westphal M; Lamszus K
    Acta Neuropathol; 2013 Nov; 126(5):763-80. PubMed ID: 24005892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.
    Flavahan WA; Wu Q; Hitomi M; Rahim N; Kim Y; Sloan AE; Weil RJ; Nakano I; Sarkaria JN; Stringer BW; Day BW; Li M; Lathia JD; Rich JN; Hjelmeland AB
    Nat Neurosci; 2013 Oct; 16(10):1373-82. PubMed ID: 23995067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo purine biosynthesis by two pathways in Burkitt lymphoma cells and in human spleen.
    Reem GH
    J Clin Invest; 1972 May; 51(5):1058-62. PubMed ID: 5020428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.
    Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T
    J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells.
    Yoon CH; Kim MJ; Kim RK; Lim EJ; Choi KS; An S; Hwang SG; Kang SG; Suh Y; Park MJ; Lee SJ
    Oncogene; 2012 Nov; 31(44):4655-66. PubMed ID: 22249269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
    Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
    Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of purine de novo synthesis in cultured human fibroblasts: the role of P-ribose-PP.
    Gordon RB; Thompson L; Johnson LA; Emmerson BT
    Biochim Biophys Acta; 1979 Mar; 562(1):162-76. PubMed ID: 435498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell markers in glioma progression and recurrence.
    Hattermann K; Flüh C; Engel D; Mehdorn HM; Synowitz M; Mentlein R; Held-Feindt J
    Int J Oncol; 2016 Nov; 49(5):1899-1910. PubMed ID: 27600094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.